[1] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J]. 中华肝脏病杂志, 2006, 14(3):161-163. [2] 张声生, 李乾构, 李军祥. 非酒精性脂肪性肝病中医诊疗共识意见[J]. 中国中西医结合消化杂志, 2011, 30(2):276-279. [3] 杜婷婷, 杜佳, 吴汉妮. 脂肪性肝病的氧化应激及其治疗对策[J]. 内科急危重症杂志, 2013, 19(4):239-242. [4] Wei B, Li Q, Fan R, et al. UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in normal and insomniac rats brain microdialysates and homogenate samples:towards an in-depth study for its sedative-hypnotic activity[J]. JMass Spectrom, 2013, 48(4):448-458. [5] 王佳丽, 杨洪涛. 五味子主要化学成分的药理研究[J]. 河南中医, 2014, 34(2):357-359. [6] 刘宏, 李贺, 苑荣爽,等. 北五味子总木脂素对C57BL/6小鼠高脂血症的影响[J]. 食品科学, 2016, 37(11):218-221. [7] 郭冷秋, 张鹏, 黄莉莉, 等. 五味子药理作用研究进展[J]. 中医药学报, 2006, 34(4):51-53. [8] 陈宝芝, 李生, 吴金滢, 等. 北五味子粗多糖对四氯化碳致小鼠急性肝损伤的保护作用及其机制[J]. 吉林大学学报:医学版, 2014, 40(1):92-96. [9] 李生, 李贺, 高晓旭, 等. 北五味子粗多糖对酒精诱导小鼠急性肝损伤的保护作用及其机制研究[J]. 北华大学学报:自然科学版, 2014, 15(4):472-475. [10] Sookoian S, Pirola CJ. Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease[J]. Publ Library Sci, 2013, 8(3):e58895-e589105. [11] Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome[J]. Hepatology, 2003, 37(4):917-923. [12] Zhu X, Bian H, Gao X. The potential mechanisms of berberine in the treatment of nonalcoholic fatty liver disease[J]. Molecules, 2016, 21(10):1336-1347. [13] Kohjima M, Enjoji M, Higuchi N, et al. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease[J]. Internat J Molecul Med, 2007, 20(3):351-358. [14] Sakaguchi S, Takahashi S, Sasaki T, et al. Progression of alcoholic and non-alcoholic steatohepatitis:common metabolic aspects of innate immune system and oxidative stress[J]. Drug Metabol Pharmacokinet, 2011, 26(1):30-46. [15] Parola M, Vajro P. Nocturnal hypoxia in obese-related obstructive sleep apnea as a putative trigger of oxidative stress in pediatric NAFLD progression[J]. J Hepatol, 2016, 65(3):470-472. [16] Sundaram S, Halbower A, Pan Z, et al. Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease[J]. JHepatol, 2016, 65(3):560-569. |